129 related articles for article (PubMed ID: 17669348)
1. [Towards a standardization of the tools for the studies of clinical proteomics].
Lucchi G; Hendra JB; Pecqueur D; Ducoroy P
Med Sci (Paris); 2007 Mar; 23 Spec No 1():19-22. PubMed ID: 17669348
[TBL] [Abstract][Full Text] [Related]
2. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
[TBL] [Abstract][Full Text] [Related]
3. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
4. [Stakes of pre-analytical parameters in blood transcriptomic and proteomic analysis. Application to clinical research: the GOELAMS trial].
Pangault C; Arlotto M; Berger F; De Vos J; Béné MC; Fest T;
Med Sci (Paris); 2007 Mar; 23 Spec No 1():13-7. PubMed ID: 17669347
[TBL] [Abstract][Full Text] [Related]
5. [Tumor proteomics: the past, present and future].
Xu XE; Jiang YH; Shi Q
Ai Zheng; 2008 Oct; 27(10):1009-17. PubMed ID: 18851778
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
7. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
Diamandis EP
Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
[No Abstract] [Full Text] [Related]
8. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
[TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
10. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
11. Proteomics in the analysis of prostate cancer.
Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
[No Abstract] [Full Text] [Related]
12. Proteomics of canine lymphoma identifies potential cancer-specific protein markers.
McCaw DL; Chan AS; Stegner AL; Mooney B; Bryan JN; Turnquist SE; Henry CJ; Alexander H; Alexander S
Clin Cancer Res; 2007 Apr; 13(8):2496-503. PubMed ID: 17438110
[TBL] [Abstract][Full Text] [Related]
13. Electrospray-assisted laser desorption/ionization and tandem mass spectrometry of peptides and proteins.
Peng IX; Shiea J; Ogorzalek Loo RR; Loo JA
Rapid Commun Mass Spectrom; 2007; 21(16):2541-6. PubMed ID: 17639579
[TBL] [Abstract][Full Text] [Related]
14. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
15. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
16. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
17. [Preanalytical guidelines for clinical proteomics investigation of biological fluids].
Lehmann S; Roche S; Allory Y; Barthelaix A; Beaudeux JL; Berger F; Betsou F; Borg J; Dupuy A; Garin J; Quillard M; Lizard G; Peoc'h K; Riviere M; Ducoroy P
Ann Biol Clin (Paris); 2009; 67(6):629-39. PubMed ID: 19939766
[TBL] [Abstract][Full Text] [Related]
18. Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Bergquist J; Palmblad M; Wetterhall M; Håkansson P; Markides KE
Mass Spectrom Rev; 2002; 21(1):2-15. PubMed ID: 12210611
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.
Petricoin EF; Liotta LA
Curr Opin Biotechnol; 2004 Feb; 15(1):24-30. PubMed ID: 15102462
[TBL] [Abstract][Full Text] [Related]
20. Imaging mass spectrometry using chemical inkjet printing reveals differential protein expression in human oral squamous cell carcinoma.
Patel SA; Barnes A; Loftus N; Martin R; Sloan P; Thakker N; Goodacre R
Analyst; 2009 Feb; 134(2):301-7. PubMed ID: 19173053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
